bupranolol has been researched along with Anoxemia in 1 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chowanetz, W | 1 |
| ter Meer, P | 1 |
| Jany, B | 1 |
1 trial available for bupranolol and Anoxemia
| Article | Year |
|---|---|
[Effect of bupranolol on hypoxic respiratory stimulation in healthy probands].
Topics: Adult; Blood Pressure; Bupranolol; Carbon Dioxide; Chemoreceptor Cells; Double-Blind Method; Electro | 1987 |